CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
A randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohns disease: Good safety profile but lack of efficacy
DOI 10.1055/s-0030-1263688
Bibliografische Angaben
Nachweis in CareLit
Autor:innenW Holtmeier, S Zeuzem, J Preiß, W Kruis, S Böhm, C Maaser, A Raedler, C Schmidt, J Schnitker, J Schwarz, M Zeitz, WF Caspary
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Complementary therapies are frequently used by patients with inflammatory bowel diseases. Aim: The aim of this study was to evaluate the efficacy and safety of long-term therapy with a new Boswellia serrata extract (Boswelan®, PS0201Bo) in maintaining remission in patients with Crohn's disease. Methods: In 22 German centers a double-blind, placebo-controlled, randomized, parallel study was performed. 1…
Zitieren
Zitierempfehlung
W Holtmeier, S Zeuzem, J Preiß, W Kruis, S Böhm, C Maaser, A Raedler, C Schmidt, J Schnitker, J Schwarz, M Zeitz, WF Caspary (2010) A randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohns disease: Good safety profile but lack of efficacy. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0030-1263688
Mit CareLit weiterarbeiten